Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Joshua Smith

Showing results (161-170 of 181) with videos related to

Pageof 19
Sort By:
BMC Cancer|July 26, 2024
Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancerJanet A Alvarez, Qian Shi, Arvind Dasari, et al.
Nature Genetics|January 5, 2021
The association between tumor mutational burden and prognosis is dependent on treatment contextCristina Valero, Mark Lee, Douglas Hoen, et al.
The New England Journal of Medicine|June 6, 2022
PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal CancerAndrea Cercek, Melissa Lumish, Jenna Sinopoli, et al.
The Oncologist|March 12, 2022
Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal CancerJin K Kim, Michael R Marco, Campbell S D Roxburgh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2019
Coaltered <i>Ras/B-raf</i> and <i>TP53</i> Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal CancerJashodeep Datta, J Joshua Smith, Walid K Chatila, et al.
JAMA Oncology|January 11, 2019
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant TherapyJ Joshua Smith, Paul Strombom, Oliver S Chow, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|December 26, 2025
A Developmental Roadmap Toward Abdominal Adhesions Prevention TechnologiesReid R Christensen, Kyla E Wright, James K Ives, et al.
Diseases of the Colon and Rectum|January 14, 2025
Correlation Between Grade of Clinical Response to Neoadjuvant Therapy for Rectal Cancer and Oncologic Outcomes in the Era of Watch-and-WaitRoni Y Rosen, Aron P Bercz, Dana M Omer, et al.
Nature Reviews. Clinical Oncology|August 5, 2021
International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancerEmmanouil Fokas, Ane Appelt, Robert Glynne-Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2024
Clinical Outcomes, Patterns of Failure, and Salvage Therapies of a Large Modern Cohort of Patients With Anal Squamous Cell Carcinoma Treated With Definitive-Intent Intensity-Modulated Radiation TherapyDiana A Roth O'Brien, Vasilis C Hristidis, Zakaria Chakrani, et al.
Pageof 19

Showing results (161-170 of 181) with videos related to

Sort By:
Pageof 19
BMC Cancer|July 26, 2024
Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancerJanet A Alvarez, Qian Shi, Arvind Dasari, et al.
Nature Genetics|January 5, 2021
The association between tumor mutational burden and prognosis is dependent on treatment contextCristina Valero, Mark Lee, Douglas Hoen, et al.
The New England Journal of Medicine|June 6, 2022
PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal CancerAndrea Cercek, Melissa Lumish, Jenna Sinopoli, et al.
The Oncologist|March 12, 2022
Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal CancerJin K Kim, Michael R Marco, Campbell S D Roxburgh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2019
Coaltered <i>Ras/B-raf</i> and <i>TP53</i> Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal CancerJashodeep Datta, J Joshua Smith, Walid K Chatila, et al.
JAMA Oncology|January 11, 2019
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant TherapyJ Joshua Smith, Paul Strombom, Oliver S Chow, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|December 26, 2025
A Developmental Roadmap Toward Abdominal Adhesions Prevention TechnologiesReid R Christensen, Kyla E Wright, James K Ives, et al.
Diseases of the Colon and Rectum|January 14, 2025
Correlation Between Grade of Clinical Response to Neoadjuvant Therapy for Rectal Cancer and Oncologic Outcomes in the Era of Watch-and-WaitRoni Y Rosen, Aron P Bercz, Dana M Omer, et al.
Nature Reviews. Clinical Oncology|August 5, 2021
International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancerEmmanouil Fokas, Ane Appelt, Robert Glynne-Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2024
Clinical Outcomes, Patterns of Failure, and Salvage Therapies of a Large Modern Cohort of Patients With Anal Squamous Cell Carcinoma Treated With Definitive-Intent Intensity-Modulated Radiation TherapyDiana A Roth O'Brien, Vasilis C Hristidis, Zakaria Chakrani, et al.
Pageof 19